stella
beta
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer — Stella
Recruiting
Back to Anatomic Stage IV Breast Cancer AJCC v8 trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
View full record on ClinicalTrials.gov